🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPharmacology & MechanismsSemaglutide fatty acid sidechain — what worked for you? Page 2

Semaglutide fatty acid sidechain — what worked for you?

AttorneyGrant Tue, Dec 2, 2025 at 11:17 AM 16 replies 1,188 viewsPage 2 of 4
anders_CPH
Senior Member
1,567
7,234
Feb 2024
Copenhagen, DK
Dec 3, 2025 at 1:43 AM#6
Dr.RenalNash said:
Albumin binding above 99% is the whole reason weekly dosing works, and it is also why the trough matters more than the peak.

I will push back on the "any working dose is fine" framing. The maintenance evidence sits overwhelmingly at the top studied dose, and the extension data shows regain tracking dose reduction rather than tracking stopping. Holding low is reasonable; pretending it is evidentially equivalent is not.

Happy to go further on any of that.

Last edited: Dec 3, 2025 at 5:43 AM
23 18CryptoCarl, MariaRD, AussieAnna and 20 others
Reply Quote Save Share Report
kate.chem
VIP Member
3,890
17,654
Dec 2023
California
Dec 3, 2025 at 7:26 AM#7

One concrete data point for the thread. Worth knowing that the injection site changes very little. Abdomen, thigh and upper arm are bioequivalent for semaglutide, so a site change is not a plausible explanation for a bad week.

22 17VanRx_Mike, steve_okc, dave_SLC and 19 others
Reply Quote Save Share Report
carl_compliance
Member
234
1,123
Nov 2024
Raleigh, NC
Dec 3, 2025 at 1:09 PM#8
anders_CPH said:
I will push back on the "any working dose is fine" framing.

There is a second half to this that has not been said yet. It helps to say which part of this you are uncertain about. A precise question gets a precise answer; a general one gets everybody’s favourite anecdote.

Last edited: Dec 3, 2025 at 4:09 PM
21 16ricardo_MIA, BrianDallas92, labquiet_amy and 18 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
emma_london
Member
312
1,456
Oct 2024
London, UK
Dec 3, 2025 at 6:52 PM#9

A narrower follow-up, since the general answer is now clear:

Was that from a primary source or from a summary of one?

20 15JessicaM_2024, TomFromTexas, mike.trainer_LA and 17 others
Reply Quote Save Share Report
AttorneyGrant
Member
567
2,890
Apr 2024
Washington, DC
Dec 4, 2025 at 10:17 PM#10

OP back with an update, since a thread like this is useless without one.

Six weeks on from posting: I stopped reading the weekly number and started reading a four-week average, and the "stall" I opened this thread about was a 1.8kg loss I could not see.

34 7Dr.GastroMayo, JakeBK_lifts, DerekSJ_a1c and 31 others
Reply Quote Save Share Report

Similar Threads

GLP-1R desensitization — β-arrestin-mediated internalization18 replies
Biased agonism at GLP-1R — Gs vs β-arrestin signaling balance13 replies
Semaglutide albumin binding and the C-18 fatty acid linker17 replies
GIP receptor pharmacology — why GIP agonism enhances GLP-113 replies
Glucagon receptor signaling — hepatic glycogenolysis and lipolysis16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register